STOCK TITAN

Exascale Labs grants director 15,000-unit stock award

The award’s vesting depends on continued service and the earlier of two milestones tied to the grant date or his director term.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Exascale Labs Holdings Inc. director David Edward Card received an award of 15,000 restricted stock units on October 6, 2026. Each unit represents a contingent right to receive one share of Class A common stock upon vesting and settlement. The units vest in full on the earlier of the first anniversary of the grant date or the scheduled expiration of his director term at an annual meeting where he is not nominated for re-election, subject to his continued service through the applicable vesting date.

Insider Card David Edward
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Units F1, F2 15,000 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 15,000 contracts (Direct)
Footnotes (2)
  1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock, par value $0.0001 per share ("Class A Common Stock"), upon vesting and settlement.
  2. F2. The RSUs were granted under the Issuer's 2026 Omnibus Equity Incentive Plan as an Initial Award under the Issuer's Non-Employee Director Compensation Policy. The RSUs vest in full on the earlier of (i) the first anniversary of the grant date and (ii) the scheduled expiration of the Reporting Person's term as a director at an annual meeting of the Issuer's stockholders at which the Reporting Person is not nominated for re-election, in each case subject to the Reporting Person's continued service through the applicable vesting date. The RSUs have no expiration date.
Restricted stock units awarded 15,000 units Awarded October 6, 2026
Underlying Class A common stock 15,000 shares Shares represented by the awarded units
Shares per restricted stock unit 1 share Contingent right upon vesting and settlement
Class A common stock par value $0.0001 per share Par value stated in the award description
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"represents a contingent right to receive one share"
vesting and settlement financial
"upon vesting and settlement"
Non-Employee Director Compensation Policy financial
"as an Initial Award under the Issuer's Non-Employee Director Compensation Policy"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many XLAB restricted stock units did David Edward Card receive?

David Edward Card received 15,000 restricted stock units on October 6, 2026. Each unit represents a contingent right to receive one share of Exascale Labs Holdings Inc. Class A common stock upon vesting and settlement.

When do David Edward Card’s XLAB restricted stock units vest?

The 15,000 restricted stock units vest in full on the earlier of the first anniversary of the grant date or the scheduled expiration of his director term at an annual meeting where he is not nominated for re-election. Vesting is subject to his continued service through the applicable vesting date.

Which plan covers David Edward Card’s XLAB restricted stock unit award?

The award was made under Exascale Labs Holdings Inc.’s 2026 Omnibus Equity Incentive Plan as an Initial Award under its Non-Employee Director Compensation Policy.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Card David Edward

(Last)(First)(Middle)
C/O EXASCALE LABS HOLDINGS INC.
820 GESSNER ROAD, SUITE 332

(Street)
HOUSTON, TEXAS 77024

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Exascale Labs Holdings Inc. [ XLAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)(1)10/06/2026A15,000 (2) (2)Class A Common Stock15,000$015,000D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock, par value $0.0001 per share ("Class A Common Stock"), upon vesting and settlement.
2. The RSUs were granted under the Issuer's 2026 Omnibus Equity Incentive Plan as an Initial Award under the Issuer's Non-Employee Director Compensation Policy. The RSUs vest in full on the earlier of (i) the first anniversary of the grant date and (ii) the scheduled expiration of the Reporting Person's term as a director at an annual meeting of the Issuer's stockholders at which the Reporting Person is not nominated for re-election, in each case subject to the Reporting Person's continued service through the applicable vesting date. The RSUs have no expiration date.
/s/ David Card10/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading